secwatch / observer
BFNH BIOFORCE NANOSCIENCES HOLDINGS, INC.
CIK 0001310488 7 ready 8-Ks latest July 1, 2026, 9:15 AM ET RSS · JSON
Activity: ELEVATED 2 filings / 30d vs 0 baseline Risk accumulating: repeated leadership change (5)
Ready 8-Ks 7
Latest filing August 18, 2026, 2:02 PM ET
Top materiality 0.90
Event mix other_material ×5 · leadership ×2
Sentiment 0 pos · 0 neg · 7 neu
Executive change recent →

Recent 8-K filings for BFNH

Executive changes

Appointed (interim)

Richard Kaiser

interim Chief Executive Officer
BFNH · BIOFORCE NANOSCIENCES HOLDINGS, INC.
Effective
2026-06-17
Filed
June 18, 2026, 8:28 AM ET
On June 17, 2026, the Company’s Board of Directors appointed Richard Kaiser as the Company’s interim Chief Executive Officer.
Departed

John LaViolette

Co-Chief Executive Officer
BFNH · BIOFORCE NANOSCIENCES HOLDINGS, INC.
Effective
2026-06-17
Successor
Richard Kaiser
Filed
June 18, 2026, 8:28 AM ET
On June 17, 2026, the Company’s Board of Directors received resignation letters from Mr. Steven Gagnon and Mr. John LaViolette as BioForce Nanosciences Holdings, Inc.’s Co-Chief Executive Officers (CEOs), and from Sasha Shapiro the Company’s Vice-President.
Appointed

Scott Mager

Director
BFNH · BIOFORCE NANOSCIENCES HOLDINGS, INC.
Effective
2026-06-15
Filed
June 18, 2026, 8:28 AM ET
Effective June 15, 2026, the Board of Directors appointed Scott Mager as Directors of the Company.
Departed

Steven Gagnon

Co-Chief Executive Officer
BFNH · BIOFORCE NANOSCIENCES HOLDINGS, INC.
Effective
2026-06-17
Successor
Richard Kaiser
Filed
June 18, 2026, 8:28 AM ET
On June 17, 2026, the Company’s Board of Directors received resignation letters from Mr. Steven Gagnon and Mr. John LaViolette as BioForce Nanosciences Holdings, Inc.’s Co-Chief Executive Officers (CEOs), and from Sasha Shapiro the Company’s Vice-President.
Departed

Sasha Shapiro

Vice-President
BFNH · BIOFORCE NANOSCIENCES HOLDINGS, INC.
Effective
2026-06-17
Filed
June 18, 2026, 8:28 AM ET
On June 17, 2026, the Company’s Board of Directors received resignation letters from Mr. Steven Gagnon and Mr. John LaViolette as BioForce Nanosciences Holdings, Inc.’s Co-Chief Executive Officers (CEOs), and from Sasha Shapiro the Company’s Vice-President.
Departed

Merle Ferguson

Chief Executive Officer and President
BFNH · BIOFORCE NANOSCIENCES HOLDINGS, INC.
Effective
2021-11-30
Successor
Steve Gagnon, John LaViolette, Sasha Shapiro
Filed
November 30, 2021, 6:59 PM ET
the Board of Directors accepted the resignation of Mr. Merle Ferguson as Chief Executive Officer and President, effective November 30, 2021.
Appointed

John LaViolette

Co-Chief Executive Officer
BFNH · BIOFORCE NANOSCIENCES HOLDINGS, INC.
Effective
2021-11-30
Filed
November 30, 2021, 6:59 PM ET
appointed both Mr. Steve Gagnon and Mr. John LaViolette as Co-Chief Executive Officers (Co-CEOs), effective November 30, 2021.
Appointed

Sasha Shapiro

President
BFNH · BIOFORCE NANOSCIENCES HOLDINGS, INC.
Effective
2021-11-30
Filed
November 30, 2021, 6:59 PM ET
appointed Sasha Shapiro as President, effective November 30, 2021.
Appointed

Steve Gagnon

Co-Chief Executive Officer
BFNH · BIOFORCE NANOSCIENCES HOLDINGS, INC.
Effective
2021-11-30
Filed
November 30, 2021, 6:59 PM ET
appointed both Mr. Steve Gagnon and Mr. John LaViolette as Co-Chief Executive Officers (Co-CEOs), effective November 30, 2021.

Materiality & sentiment trend

Max materiality 0.90 · Median 0.55 · Most common event other_material

0 positive 0 negative 7 neutral

source · BFNH on sec.gov